Navigation Links
Net advantage
Date:3/7/2013

Malaria, the leading cause of death among children in Africa, could be eliminated if three-fourths of the population used insecticide-treated bed nets, according to a new study from the National Institute for Mathematical and Biological Synthesis (NIMBioS).

The study, which uses a mathematical model, found that use of insecticide-treated bed nets or ITNs positively affected the infection's reproduction number, or R, which is the primary epidemiological number used to determine the degree which a disease can spread through a population. The model concludes that if 75 percent of the population were to use ITNs, malaria could be eliminated.

The treated mosquito net forms a protective barrier around people sleeping under them. The insecticide not only kills the mosquitoes, which carry the malaria parasite, and other insects, it also repels mosquitoes, reducing the number that enter the house and attempt to feed on people inside. With ITNs, the number of mosquitoes, as well as their length of life, is reduced, which is why the density of nets in a community is important.

Overcoming cultural resistance to using bed nets in communities where people view the nets as intrusive has been a major challenge of international malaria prevention agencies, however. There is evidence also that in some countries more bed nets go to the rich than the poor. Health groups are devising strategies to encourage use of the bed nets and to make sure they are distributed more equitably.

"Based on the results, it's clear that educational campaigns around the use of bed-nets must continue as the nets play a critical role in reducing the transmission of malaria," said Folashade Agusto, the study's lead author and participant in the NIMBioS Investigative Workshop on Malaria Modeling and Control, whose other participants co-authored the study. A former NIMBioS postdoctoral fellow, Agusto is an assistant professor of mathematics at Austin Peay State University.

Malaria has already been eradicated in Europe, North America, the Caribbean, and parts of Asia and South-Central America, and yet, the World Health Organization estimates that every year 250 million people become infected with malaria and nearly one million die.


'/>"/>

Contact: Catherine Crawley
ccrawley@nimbios.org
865-974-9350
National Institute for Mathematical and Biological Synthesis (NIMBioS)
Source:Eurekalert

Related biology news :

1. Video-gaming fish play out the advantages of groups
2. Syracuse University study finds autumn advantage for invasive plants in eastern United States
3. Weakness can be an advantage in surviving deadly parasites, a new study shows
4. Evolving to fight epidemics: Weakness can be an advantage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... The biometrics market has reached a ... organizations, desires to better authenticate or identify users ... challenge questions), biometrics is quickly working its way ... is driven by use cases, though there traditionally ... uses cases, with consumer-facing use cases encompassing authentication, ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... -- Financial Highlights ... unaudited)Three Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$   ... Product Revenue 3539(10)%9498(4)%Kuvan Net Product ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
(Date:2/23/2017)... ... 2017 , ... David Nolte, PhD accepted Purdue University’s 2016 ... Research Park of West Lafayette, Indiana. , The top commercialization award is ... success with, commercializing discoveries from Purdue research. “This award is truly an honor. ...
Breaking Biology Technology: